HK1042500A1 - Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant - Google Patents

Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Info

Publication number
HK1042500A1
HK1042500A1 HK02104068A HK02104068A HK1042500A1 HK 1042500 A1 HK1042500 A1 HK 1042500A1 HK 02104068 A HK02104068 A HK 02104068A HK 02104068 A HK02104068 A HK 02104068A HK 1042500 A1 HK1042500 A1 HK 1042500A1
Authority
HK
Hong Kong
Prior art keywords
artificial
preparation
surface activity
surfactant
peptides
Prior art date
Application number
HK02104068A
Other languages
English (en)
Inventor
Tore Curstedt
Jan Johansson
Hans Jornvall
Bengt Robertson
Paolo Ventura
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of HK1042500A1 publication Critical patent/HK1042500A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02104068A 1999-02-12 2002-05-31 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant HK1042500A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000275A IT1308180B1 (it) 1999-02-12 1999-02-12 Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
PCT/EP2000/001044 WO2000047623A1 (en) 1999-02-12 2000-02-09 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Publications (1)

Publication Number Publication Date
HK1042500A1 true HK1042500A1 (en) 2002-08-16

Family

ID=11381859

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104068A HK1042500A1 (en) 1999-02-12 2002-05-31 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Country Status (33)

Country Link
US (1) US7053044B1 (et)
EP (1) EP1151008B1 (et)
JP (1) JP4754073B2 (et)
KR (1) KR100645145B1 (et)
CN (1) CN1221570C (et)
AR (1) AR022578A1 (et)
AT (1) ATE280181T1 (et)
AU (1) AU758735B2 (et)
BG (1) BG65196B1 (et)
BR (1) BR0009964A (et)
CA (1) CA2362507C (et)
CO (1) CO5241361A1 (et)
CZ (1) CZ301108B6 (et)
DE (1) DE60015082T2 (et)
EA (1) EA004058B1 (et)
EE (1) EE04879B1 (et)
ES (1) ES2228473T3 (et)
GE (1) GEP20032976B (et)
HK (1) HK1042500A1 (et)
HU (1) HU228997B1 (et)
IL (1) IL144842A0 (et)
IT (1) IT1308180B1 (et)
MA (1) MA25381A1 (et)
NO (1) NO20013888D0 (et)
NZ (1) NZ513451A (et)
PL (1) PL201084B1 (et)
PT (1) PT1151008E (et)
SK (1) SK286428B6 (et)
TR (1) TR200102308T2 (et)
UA (1) UA72751C2 (et)
WO (1) WO2000047623A1 (et)
YU (1) YU57701A (et)
ZA (1) ZA200106530B (et)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
JP2003522138A (ja) * 2000-02-11 2003-07-22 アルタナ ファルマ アクチエンゲゼルシャフト 慢性肺疾患の予防および治療のための肺表面活性剤の新規使用
EP1340506B1 (en) * 2002-03-01 2006-12-27 CHIESI FARMACEUTICI S.p.A. Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
AU2003302740A1 (en) * 2002-12-09 2004-07-14 Children's Hospital Medical Center Methods of diagnosis and treatment of interstitial lung disease
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
CA2536453A1 (en) * 2003-08-28 2005-03-10 Altana Pharma Ag Use of surfactant preparations for the treatment of surgical adhesions
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
DK2078038T3 (da) * 2006-10-13 2013-12-02 Chiesi Farma Spa Rekonstituerede surfaktanter med forbedrede egenskaber
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
AR074874A1 (es) 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
RU2538675C2 (ru) 2009-09-08 2015-01-10 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Терапевтическая комбинация, включающая легочный сурфактант и антиоксидантные ферменты
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
BR112014026212A8 (pt) * 2012-04-23 2019-12-24 Chiesi Farm Spa equipamento para administração de medicamento, processo para administração de um medicamento e uso de um equipamento para administração de medicamento
ES2644317T3 (es) * 2012-11-21 2017-11-28 Chiesi Farmaceutici S.P.A. Tensioactivos pulmonares reconstituidos
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
CN107666933A (zh) 2015-04-22 2018-02-06 奇斯药制品公司 用于药物有效地呼吸同步递送到肺部的方法和系统
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
CN107979996A (zh) * 2015-04-30 2018-05-01 不莱梅大学 新的皮肤医疗和美容护理产品
CA3028551A1 (en) 2016-07-28 2018-02-01 Chiesi Farmaceutici S.P.A. Method and system for delivery of an aerosolized medicament
BR112019008169A2 (pt) 2016-10-26 2019-07-09 Chiesi Farm Spa dispositivo para facilitar o posicionamento de um cateter, sistema para entrega de um medicamento em aerossol por meio de um cateter, método para utilização de um dispositivo e kit
EP3558376B1 (en) 2016-12-22 2021-10-20 Chiesi Farmaceutici S.p.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving bpd
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
AU2019260526A1 (en) 2018-04-23 2020-11-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114159546A (zh) * 2021-12-20 2022-03-11 双鹤药业(海南)有限责任公司 新一代合成肺表面活性物质制剂及其临床应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
EP0733645B1 (en) * 1993-12-08 2003-03-19 Mitsubishi Pharma Corporation Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
IT1308180B1 (it) 2001-12-07
CA2362507A1 (en) 2000-08-17
EP1151008A1 (en) 2001-11-07
HUP0200141A2 (en) 2002-06-29
DE60015082D1 (de) 2004-11-25
ITMI990275A1 (it) 2000-08-12
PL349785A1 (en) 2002-09-09
CA2362507C (en) 2012-01-03
HU228997B1 (en) 2013-07-29
AR022578A1 (es) 2002-09-04
US7053044B1 (en) 2006-05-30
PL201084B1 (pl) 2009-03-31
KR20010101904A (ko) 2001-11-15
ATE280181T1 (de) 2004-11-15
EA200100749A1 (ru) 2002-02-28
EE200100413A (et) 2002-12-16
EA004058B1 (ru) 2003-12-25
JP4754073B2 (ja) 2011-08-24
CO5241361A1 (es) 2003-01-31
KR100645145B1 (ko) 2006-11-10
TR200102308T2 (tr) 2002-04-22
MA25381A1 (fr) 2002-04-01
NO20013888L (no) 2001-08-09
BG65196B1 (bg) 2007-06-29
IL144842A0 (en) 2002-06-30
EP1151008B1 (en) 2004-10-20
SK11442001A3 (sk) 2001-12-03
CN1221570C (zh) 2005-10-05
DE60015082T2 (de) 2006-02-09
PT1151008E (pt) 2005-01-31
UA72751C2 (en) 2005-04-15
AU3279300A (en) 2000-08-29
CZ20012876A3 (cs) 2002-06-12
CN1340060A (zh) 2002-03-13
ES2228473T3 (es) 2005-04-16
BG105764A (en) 2002-03-29
ZA200106530B (en) 2002-10-14
NZ513451A (en) 2003-05-30
NO20013888D0 (no) 2001-08-09
WO2000047623A1 (en) 2000-08-17
CZ301108B6 (cs) 2009-11-11
SK286428B6 (sk) 2008-09-05
GEP20032976B (en) 2003-05-27
HUP0200141A3 (en) 2002-09-30
AU758735B2 (en) 2003-03-27
BR0009964A (pt) 2002-04-09
YU57701A (sh) 2003-07-07
JP2002541062A (ja) 2002-12-03
EE04879B1 (et) 2007-08-15

Similar Documents

Publication Publication Date Title
HK1042500A1 (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
IL145715A0 (en) Formulation arrays and use thereof
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
HUP0000963A3 (en) The use of levobupivacaine in paediatric surgery
HUP0000873A3 (en) The use of levobupivacaine in facial surgery
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
AU4301100A (en) Isolated peptide of the horny layer and use thereof
ZA983239B (en) Stable active human ob protein compositions and methods
EP1086215A4 (en) PREPARATION AND USE OF HIGHER VACCINES
EP1308509A4 (en) NEW, PHYSIOLOGICALLY ACTIVE PEPTIDE AND ITS APPLICATIONS
IL131719A0 (en) Iren protein its preparation and use
SI1151008T1 (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
GB2351459B (en) Improvements in and relating to the application of materials
GB9912085D0 (en) Use of amino acids in hair treatment
EP1275659A4 (en) PHYSIOLOGICALLY ACTIVE PEPTIDES AND THEIR USE
NZ329917A (en) Peptides having somatostatin antagonistic activity and their use in the enhancement of meat production
GB9927353D0 (en) Virus preparation and use
IL156077A0 (en) Analogues of thiocoraline and be-22179
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof
EP1150685A4 (en) SURFACTANTS BASED ON PHOSPHOCHOLINE AND USES THEREOF
HK1047116A1 (zh) 來自mage的免疫原性肽及其應用
HUP0200775A3 (en) Use of pegylated interferon-alpha in melanoma therapy
GB9905300D0 (en) Therapy and use of agents in therapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160209